Société des Produits Nestlé S.A. (SPN), a Nestle(OTCPK:NSRGY)subsidiary announces the results of the tender offer, to purchase all of the outstanding shares of Aimmune Therapeutics'(NASDAQ:AIMT)common stock for $34.50/share. The offer expired on October 9.
Equinity Trust Company, the depositary for the offer, has advised Nestlé that, 43,435,583 shares were validly tendered and not withdrawn, which represents, ~84% of the outstanding shares as of the Expiration Date.
See below overview of Nestle business over past 150 years:
Previously: Nestle to buy Aimmune Therapeutics for $2.6B (Aug. 31)
Click to subscribe to real-time analytics on NSRGY
Now read:Merger Arbitrage Analysis And Spread Performance - October 11, 2020 »